Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
November 10, 2018
Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema
William D Cornwell, Cynthia Kim, Alejandra C Lastra, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2020
Off-Target <i>In Vitro</i> Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent
Yili Xu, Ona Barauskas, Cynthia Kim, et al.
Viruses
|
June 27, 2025
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?
Darius Babusis, Cynthia Kim, Jesse Yang, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2021
Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells
Ruidong Li, Albert Liclican, Yili Xu, et al.
Science Translational Medicine
|
December 30, 2021
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection
Meghan S Vermillion, Eisuke Murakami, Bin Ma, et al.
Journal of Medicinal Chemistry
|
April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV
Richard L Mackman, Hon C Hui, Michel Perron, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
November 10, 2018
Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema
William D Cornwell, Cynthia Kim, Alejandra C Lastra, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2020
Off-Target <i>In Vitro</i> Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent
Yili Xu, Ona Barauskas, Cynthia Kim, et al.
Viruses
|
June 27, 2025
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?
Darius Babusis, Cynthia Kim, Jesse Yang, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2021
Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells
Ruidong Li, Albert Liclican, Yili Xu, et al.
Science Translational Medicine
|
December 30, 2021
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection
Meghan S Vermillion, Eisuke Murakami, Bin Ma, et al.
Journal of Medicinal Chemistry
|
April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV
Richard L Mackman, Hon C Hui, Michel Perron, et al.
Page
of 2